Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harrison.ai has developed clinically validated, commercial-grade AI solutions that significantly improve diagnostic accuracy and efficiency in radiology and pathology. Their Annalise CXR product improves chest X-ray interpretation accuracy by up to 45% and efficiency by over 12%, with real-world studies showing earlier lung cancer detection by an average of sixteen months. The company’s new foundational model, Harrison.rad.1, outperforms generic large language models on radiological tasks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harrison.ai.